A CD33-specific single-chain immunotoxin mediates potent apoptosis of cultured human myeloid leukaemia cells

British Journal of Haematology

Volumn 133, Issue 2, 2006, Pages 141-151

  Schwemmlein, Michael ^a   Peipp, Matthias ^b   Barbin, Karin ^a   Saul, Domenica ^a   Stockmeyer, Bernhard ^a   Repp, Roland ^b   Birkmann, Josef ^c   Oduncu, Fuat ^d   Emmerich, Bertold ^d   Fey, Georg H ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c City Hosp   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Acute myeloid leukaemia; Antibody therapy; CD33; Exotoxin A; Immunotoxin

Indexed keywords

CD33 ANTIGEN; IMMUNOTOXIN; PSEUDOMONAS EXOTOXIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD; BONE MARROW CELL; CONTROLLED STUDY; CYTOTOXICITY; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; LEUKEMIA CELL; MOUSE; MYELOID LEUKEMIA; NONHUMAN; PRIORITY JOURNAL;

ADP RIBOSE TRANSFERASES; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; APOPTOSIS; BACTERIAL TOXINS; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES; EXOTOXINS; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN FRAGMENTS; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOTOXINS; LEUKEMIA, MYELOID; MICE; MICE, INBRED BALB C; RECOMBINANT FUSION PROTEINS; TUMOR CELLS, CULTURED; U937 CELLS; VIRULENCE FACTORS;

EID: 33645063449     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05869.x     Document Type: Article

References (47)

1. Amico D. Barbui A.M. Erba E. Rambaldi A. Introna M. Golay J. 2003 Differential response of human acute myeloid leukemia cells to gemtuzumab ozogamicin in vitro: role of Chk1 and Chk2 phosphorylation and caspase 3 Blood 101 4589 4597
2. Appelbaum F.R. 1999 Antibody-targeted therapy for myeloid leukemia Seminars in Hematology 36 2 8
3. Appelbaum F.R. Rowe J.M. Radich J. Dick J.E. 2001 Acute myeloid leukemia Hematology/American Society of Hematology. Education Program 62 86
4. Baluna R. Rizo J. Gordon B.E. Ghetie V. Vitetta E.S. 1999 Evidence for a structural motif in toxins and interleukin-2 that may be responsible for binding to endothelial cells and initiating vascular leak syndrome Proceedings of the National Academy of Sciences of the United States of America 96 3957 3962
5. Barth S. Huhn M. Matthey B. Tawadros S. Schnell R. Schinkothe T. Diehl V. Engert A. 2000 Ki-4(scFv)-ETA′, a new recombinant anti-CD30 immunotoxin with highly specific cytotoxic activity against disseminated Hodgkin tumors in SCID mice Blood 95 3909 3914
6. Brinkmann U. Pai L.H. FitzGerald D.J. Willingham M. Pastan I. 1991 B3(Fv)-PE38KDEL, a single-chain immunotoxin that causes complete regression of a human carcinoma in mice Proceedings of the National Academy of Sciences of the United States of America 88 8616 8620
7. Bross P.F. Beitz J. Chen G. Chen X.H. Duffy E. Kieffer L. Roy S. Sridhara R. Rahman A. Williams G. Pazdur R. 2001 Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia Clinical Cancer Research 7 1490 1496
8. Caron P.C. Schwartz M.A. Co M.S. Queen C. Finn R.D. Graham M.C. Divgi C.R. Larson S.M. Scheinberg D.A. 1994 Murine and humanized constructs of monoclonal antibody M195 (anti-CD33) for the therapy of acute myelogenous leukemia Cancer 73 1049 1056
9. Dinndorf P.A. Andrews R.G. Benjamin D. Ridgway D. Wolff L. Bernstein I.D. 1986 Expression of normal myeloid-associated antigens by acute leukemia cells Blood 67 1048 1053
10. Dorrie J. Gerauer H. Wachter Y. Zunino S.J. 2001 Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells Cancer Research 61 4731 4739
11. Drexler H.G. 2001 The Leukemia-lymphoma Cell Line Facts Book Academic Press San Diego, CA
12. Freeman S.D. Kelm S. Barber E.K. Crocker P.R. 1995 Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules Blood 85 2005 2012
13. Grossbard M.L. Lambert J.M. Goldmacher V.S. Spector N.L. Kinsella J. Eliseo L. Coral F. Taylor J.A. Blattler W.A. Epstein C.L. Nadler L.M. 1993 Anti-B4-blocked ricin: a phase I trial of 7-day continuous infusion in patients with B-cell neoplasms Journal of Clinical Oncology 11 726 737
14. Hamann P.R. Hinman L.M. Hollander I. Beyer C.F. Lindh D. Holcomb R. Hallett W. Tsou H.R. Upeslacis J. Shochat D. Mountain A. Flowers D.A. Bernstein I. 2002 Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia Bioconjugate Chemistry 13 47 58
15. Harlow E. Lane D. 1998 Using Antibodies: A Laboratory Manual Cold Spring Harbor Laboratory Press Cold Spring Harbor, NY
16. Jedema I. Barge R.M. van der Velden V.H. Nijmeijer B.A. van Dongen J.J. Willemze R. Falkenburg J.H. 2004a Internalization and cell cycle-dependent killing of leukemic cells by Gemtuzumab Ozogamicin: rationale for efficacy in CD33-negative malignancies with endocytic capacity Leukemia 18 316 325
17. Jedema I. Barge R.M. Frankel A.E. Willemze R. Falkenburg J.H. 2004b Acute myeloid leukemia cells in G0 phase of the cell cycle that are unresponsive to conventional chemotherapy are sensitive to treatment with granulocyte-macrophage colony-stimulating factor/diphtheria toxin fusion proteins Experimental Hematology 32 188 194
18. Jemal A. Tiwari R.C. Murray T. Ghafoor A. Samuels A. Ward E. Feuer E.J. Thun M.J. 2004 Cancer statistics, 2004 CA Cancer Journal for Clinicians 54 8 29
19. Kounnas M.Z. Morris R.E. Thompson M.R. FitzGerald D.J. Strickland D.K. Saelinger C.B. 1992 The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds and internalizes Pseudomonas exotoxin A Journal of Biological Chemistry 267 12420 12423
20. Krebber A. Bornhauser S. Burmester J. Honegger A. Willuda J. Bosshard H.R. Pluckthun A. 1997 Reliable cloning of functional antibody variable domains from hybridomas and spleen cell repertoires employing a reengineered phage display system Journal of Immunological Methods 201 35 55
21. Kreitman R.J. Wilson W.H. White J.D. Stetler-Stevenson M. Jaffe E.S. Giardina S. Waldmann T.A. Pastan I. 2000 Phase I trial of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) in patients with hematologic malignancies Journal of Clinical Oncology 18 1622 1636
22. Kreitman R.J. Wilson W.H. Bergeron K. Raggio M. Stetler-Stevenson M. FitzGerald D.J. Pastan I. 2001 Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia New England Journal of Medicine 345 241 247
23. Laemmli U.K. 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 680 685
24. Lang P. Barbin K. Feuchtinger T. Greil J. Peipp M. Zunino S.J. Pfeiffer M. Handgretinger R. Niethammer D. Fey G.H. 2004 Chimeric CD19 antibody mediates cytotoxic activity against leukemic blasts with effector cells from pediatric patients who received T-cell-depleted allografts Blood 103 3982 3985
25. Larson R.A. Boogaerts M. Estey E. Karanes C. Stadtmauer E.A. Sievers E.L. Mineur P. Bennett J.M. Berger M.S. Eten C.B. Munteanu M. Loken M.R. Van Dongen J.J. Bernstein I.D. Appelbaum F.R. 2002 Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin) Leukemia 16 1627 1636
26. Loewenberg B. Downing J.R. Burnett A. 1999 Acute Myeloid Leukemia New England Journal of Medicine 341 1051 1062
27. Lord J.M. Smith D.C. Roberts L.M. 1999 Toxin entry: how bacterial proteins get into mammalian cells Cellular Microbiology 1 85 91
28. Meeker T.C. Miller R.A. Link M.P. Bindl J. Warnke R. Levy R. 1984 A unique human B lymphocyte antigen defined by a monoclonal antibody Hybridoma 3 305 320
29. Mingari M.C. Vitale C. Romagnani C. Falco M. Moretta L. 2001 p75/AIRM1 and CD33, two sialoadhesin receptors that regulate the proliferation or the survival of normal and leukemic myeloid cells Immunological Reviews 181 260 268
30. Munro S. Pelham H.R. 1987 A C-terminal signal prevents secretion of luminal ER proteins Cell 48 899 907
31. Nicoletti I. Migliorati G. Pagliacci M.C. Grignani F. Riccardi C. 1991 A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry Journal of Immunological Methods 139 271 279
32. Paul S.P. Taylor L.S. Stansbury E.K. McVicar D.W. 2000 Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2 Blood 96 483 490
33. Peipp M. Simon N. Loichinger A. Baum W. Mahr K. Zunino S.J. Fey G.H. 2001 An improved procedure for the generation of recombinant single-chain Fv antibody fragments reacting with human CD13 on intact cells Journal of Immunological Methods 251 161 176
34. Peipp M. Kupers H. Saul D. Schlierf B. Greil J. Zunino S.J. Gramatzki M. Fey G.H. 2002 A recombinant CD7-specific single-chain immunotoxin is a potent inducer of apoptosis in acute leukemic T cells Cancer Research 62 2848 2855
35. Sambrook J. Russel D.W. 2001 Molecular Cloning: A Laboratory Manual 3rd edn Cold Spring Harbour Laboratory Press Cold Spring Harbour, NY
36. Schnell R. Vitetta E. Schindler J. Barth S. Winkler U. Borchmann P. Hansmann M.L. Diehl V. Ghetie V. Engert A. 1998 Clinical trials with an anti-CD25 ricin A-chain experimental and immunotoxin (RFT5-SMPT-dgA) in Hodgkin's lymphoma Leukemia and Lymphoma 30 525 537
37. Seetharam S. Chaudhary V.K. FitzGerald D. Pastan I. 1991 Increased cytotoxic activity of Pseudomonas exotoxin and two chimeric toxins ending in KDEL Journal of Biological Chemistry 266 17376 17381
38. Sievers E.L. 2001 Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukaemia in first relapse Expert Opinion on Biological Therapy 1 893 901
39. Sievers E.L. Appelbaum F.R. Spielberger R.T. Forman S.J. Flowers D. Smith F.O. Shannon-Dorcy K. Berger M.S. Bernstein I.D. 1999 Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of an anti-CD33 calicheamicin immunoconjugate Blood 93 3678 3684
40. Simmons D. Seed B. 1988 Isolation of a cDNA encoding CD33, a differentiation antigen of myeloid progenitor cells Journal of Immunology 141 2797 2800
41. Skerra A. Schmidt T.G. 2000 Use of the Strep-Tag and streptavidin for detection and purification of recombinant proteins Methods in Enzymology 326 271 304
42. Tur M.K. Huhn M. Thepen T. Stocker M. Krohn R. Vogel S. Jost E. Osieka R. de Winkel J.G. Fischer R. Finnern R. Barth S. 2003 Recombinant CD64-specific single chain immunotoxin exhibits specific cytotoxicity against acute myeloid leukemia cells Cancer Research 63 8414 8419
43. van der Velden V. te Marvelde J.G. Hoogeveen P.G. Bernstein I.D. Houtsmuller A.B. Berger M.S. 2001 Targeting of the CD33-calicheamicin immunoconjugate Mylotarg (CMA-676) in acute myeloid leukemia: in vivo and in vitro saturation and internalization by leukemic and normal myeloid cells Blood 97 3197 3204
44. Vermes I. Haanen C. Steffens-Nakken H. Reutelingsperger C. 1995 A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V Journal of Immunological Methods 184 39 51
45. Wellhausen S.R. Peiper S.C. 2002 CD33: biochemical and biological characterization and evaluation of clinical relevance Journal of Biological Regulators and Homeostatic Agents 16 139 143
46. Wels W. Beerli R. Hellmann P. Schmidt M. Marte B.M. Kornilova E.S. Hekele A. Mendelsohn J. Groner B. Hynes N.E. 1995 EGF receptor and p185erbB-2-specific single-chain antibody toxins differ in their cell-killing activity on tumor cells expressing both receptor proteins International Journal of Cancer 60 137 144
47. Zein N. Sinha A.M. McGahren W.J. Ellestad G.A. 1988 Calicheamicin gamma 1I: an antitumor antibiotic that cleaves double-stranded DNA site specifically Science 240 1198 1201